3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
86
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
1
Classical hematology
1
Conditions
Thalassemia
1
Immunologic Deficiency Syndromes
1
Hemoglobinopathies
1
Hematologic Neoplasms
1
Fanconi Anemia
1
Anemia, Sickle Cell
1
Interventions
Rivaroxaban
8
Surveys and Questionnaires
7
Heparin, Low-Molecular-Weight
5
apixaban
4
fludarabine
3
Blood Specimen Collection
3
pegfilgrastim
2
epoetin beta
2
Therapeutics
2
Polymerase Chain Reaction
2
Piperacillin, Tazobactam Drug Combination
2
Observation
2
Microarray Analysis
2
Melphalan
2
Influenza Vaccines
2
Immunoenzyme Techniques
2
Flow Cytometry
2
Epoetin Alfa
2
Data Collection
2
Dabigatran
2
Biopsy
2
ziprasidone
1
ribociclib
1
ravulizumab
1
palbociclib
1
oprelvekin
1
iron isomaltoside 1000
1
fludarabine phosphate
1
edoxaban
1
calcium heparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
fludarabine phosphate
×
Classical hematology
×
Clear all
NCT01316549
2021-10-04
HCT
University of California, San Francisco
Completed
67 enrolled